======= TMEM189 =======
== Gene Information ==
* **Official Symbol**: TMEM189
* **Official Name**: transmembrane protein 189
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=387521|387521]]
* **UniProt**: [[https://www.uniprot.org/uniprot/A5PLL7|A5PLL7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TMEM189&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TMEM189|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|Kua-UEV1 localn|
|endoplasmic reticulum membrane|
|endoplasmic reticulum|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp507|Monensin 0.3μM R08 exp507]]|-3.49|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-3.32|
|[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-2.97|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.71|
|[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.45|
|[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.35|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.3|
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-2.13|
|[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|-2.11|
|[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-2.04|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.04|
|[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-1.99|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|-1.83|
|[[:results:exp461|BS-181 20μM R08 exp461]]|-1.82|
|[[:results:exp493|IL-3 9ng/ml R08 exp493]]|-1.78|
|[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.77|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.71|
|[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.7|
|[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.77|
|[[:results:exp292|Menadione 5μM R06 exp292]]|1.82|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|1.88|
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|3.28|
^Gene^Correlation^
|[[:human genes:e:ept1|EPT1]]|0.549|
|[[:human genes:a:agps|AGPS]]|0.451|
|[[:human genes:f:far1|FAR1]]|0.44|
|[[:human genes:p:pex1|PEX1]]|0.435|
|[[:human genes:p:pcyt2|PCYT2]]|0.401|
Global Fraction of Cell Lines Where Essential: 2/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|2/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4829
* **Expression level (log2 read counts)**: 5.39
{{:chemogenomics:nalm6 dist.png?nolink |}}